mRNA |
Doxorubicin |
FIMM |
pan-cancer |
AAC |
0.4 |
0.005 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.007 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.008 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.11 |
0.01 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.01 |